Hyunsun Jo

Hyunsun Jo

Company: Pin Therapeutics

Job title: Founder & Chief Executive Officer


Approaches to Develop a Molecular Glue Degrader That Degrades Undruggable Transcription Factors 9:30 am

• Ternary complex formation assay • Reviewing the phenotypic screening method • Evaluating a real example for specific target proteinRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.